Health
Arthritis drug trialled as potential treatment for COVID-19 – Arab News
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19. The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foun…
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19.
The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foundation Trust (MFT).
The OSCAR study (Otilimab in Severe COVID-19 Related Disease) is sponsored and funded by the pharmaceutical company GlaxoSmithKline.
The study at the MRI is being led by Dr. Andy Martin, an Intensive Care and Anaest…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General10 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate